170 related articles for article (PubMed ID: 9134533)
1. [Monoamines, monoamine metabolites, neuron specific enolase and myelin basic protein concentrations in cerebrospinal fluid of resuscitated patients].
Takahashi T
Nihon Shinkei Seishin Yakurigaku Zasshi; 1997 Feb; 17(1):7-16. PubMed ID: 9134533
[TBL] [Abstract][Full Text] [Related]
2. Neuron-specific enolase and myelin basic protein: relationship of cerebrospinal fluid concentrations to the neurologic condition of asphyxiated full-term infants.
Garcia-Alix A; Cabañas F; Pellicer A; Hernanz A; Stiris TA; Quero J
Pediatrics; 1994 Feb; 93(2):234-40. PubMed ID: 7510064
[TBL] [Abstract][Full Text] [Related]
3. [Concentrations of monoamines and monoamine metabolites in cerebrospinal fluid determined by high-performance liquid chromatography with electrochemical detection].
Yoshino K
No To Shinkei; 1982 Nov; 34(11):1099-106. PubMed ID: 6186264
[TBL] [Abstract][Full Text] [Related]
4. [Age changes in concentrations of monoamines and related substances in the cerebrospinal fluid].
Takahashi S; Abe T
No To Shinkei; 1991 Apr; 43(4):331-6. PubMed ID: 1716119
[TBL] [Abstract][Full Text] [Related]
5. Monoamine metabolites in cerebrospinal fluid during acute cerebral ischemia.
Tang HZ; Lu XF; Wang KJ; Ou YS; Huang YQ
Chin Med J (Engl); 1989 Jan; 102(1):18-23. PubMed ID: 2475306
[TBL] [Abstract][Full Text] [Related]
6. Effect of vagus nerve stimulation on cerebrospinal fluid monoamine metabolites, norepinephrine, and gamma-aminobutyric acid concentrations in depressed patients.
Carpenter LL; Moreno FA; Kling MA; Anderson GM; Regenold WT; Labiner DM; Price LH
Biol Psychiatry; 2004 Sep; 56(6):418-26. PubMed ID: 15364040
[TBL] [Abstract][Full Text] [Related]
7. Serum neuron-specific enolase, S100B, and myelin basic protein concentrations after inflicted and noninflicted traumatic brain injury in children.
Berger RP; Adelson PD; Pierce MC; Dulani T; Cassidy LD; Kochanek PM
J Neurosurg; 2005 Jul; 103(1 Suppl):61-8. PubMed ID: 16122007
[TBL] [Abstract][Full Text] [Related]
8. Monoamines in the brain cerebrospinal fluid of facial pain patients.
Bouckoms AJ; Sweet WH; Poletti C; Lavori P; Carr D; Matson W; Gamache P; Aronin N
Anesth Prog; 1992; 39(6):201-8. PubMed ID: 7504420
[TBL] [Abstract][Full Text] [Related]
9. Monoamine metabolites in normal human cerebrospinal fluid and in degenerative diseases of the central nervous system.
González-Quevedo A; García JC; Fernández R; Fernández Cartaya L
Bol Estud Med Biol; 1993; 41(1-4):13-9. PubMed ID: 7521168
[TBL] [Abstract][Full Text] [Related]
10. Serum neuron-specific enolase as early predictor of outcome after in-hospital cardiac arrest: a cohort study.
Rech TH; Vieira SR; Nagel F; Brauner JS; Scalco R
Crit Care; 2006; 10(5):R133. PubMed ID: 16978415
[TBL] [Abstract][Full Text] [Related]
11. [Role of neuron specific enolase and S100 protein in evaluation of brain damage in patients resuscitated from cardiac arrest].
Miao WL; Li HL; Wang HD; Wang J; Liu H; Ren HX; Lin HY
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Dec; 19(12):749-52. PubMed ID: 18093437
[TBL] [Abstract][Full Text] [Related]
12. Outcome after cardiac arrest: predictive values and limitations of the neuroproteins neuron-specific enolase and protein S-100 and the Glasgow Coma Scale.
Pfeifer R; Börner A; Krack A; Sigusch HH; Surber R; Figulla HR
Resuscitation; 2005 Apr; 65(1):49-55. PubMed ID: 15797275
[TBL] [Abstract][Full Text] [Related]
13. Serum- and CSF-concentrations of brain specific proteins in hydrocephalus.
Beems T; Simons KS; Van Geel WJ; De Reus HP; Vos PE; Verbeek MM
Acta Neurochir (Wien); 2003 Jan; 145(1):37-43. PubMed ID: 12545260
[TBL] [Abstract][Full Text] [Related]
14. Circadian rhythm of CSF monoamines and hypocretin-1 in restless legs syndrome and Parkinson's disease.
Poceta JS; Parsons L; Engelland S; Kripke DF
Sleep Med; 2009 Jan; 10(1):129-33. PubMed ID: 18207455
[TBL] [Abstract][Full Text] [Related]
15. Monoamine metabolites in ventricular CSF of children with posterior fossa tumors: correlation with tumor histology and cognitive functioning.
Varela M; Alexiou GA; Liakopoulou M; Papakonstantinou E; Pitsouni D; Alevizopoulos GA
J Neurosurg Pediatr; 2014 Apr; 13(4):375-9. PubMed ID: 24559277
[TBL] [Abstract][Full Text] [Related]
16. Cerebrospinal fluid biomarkers showing neurodegeneration in dogs with GM1 gangliosidosis: possible use for assessment of a therapeutic regimen.
Satoh H; Yamato O; Asano T; Yonemura M; Yamauchi T; Hasegawa D; Orima H; Arai T; Yamasaki M; Maede Y
Brain Res; 2007 Feb; 1133(1):200-8. PubMed ID: 17196562
[TBL] [Abstract][Full Text] [Related]
17. Uncoupling of serotonergic and noradrenergic systems in depression: preliminary evidence from continuous cerebrospinal fluid sampling.
Geracioti TD; Loosen PT; Ekhator NN; Schmidt D; Chambliss B; Baker DG; Kasckow JW; Richtand NM; Keck PE; Ebert MH
Depress Anxiety; 1997; 6(3):89-94. PubMed ID: 9442982
[TBL] [Abstract][Full Text] [Related]
18. Cerebrospinal fluid levels of monoamine compounds and cholecystokinin peptides after exposure to standardized barometric pressure.
Eklundh T; Gunnarsson T; Ornhagen H; Nordin C
Aviat Space Environ Med; 2000 Nov; 71(11):1131-6. PubMed ID: 11086668
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic pitfalls in patients with hypoxic brain damage: three case reports.
Zingler VC; Pohlmann-Eden B
Resuscitation; 2005 Apr; 65(1):107-10. PubMed ID: 15797283
[TBL] [Abstract][Full Text] [Related]
20. [A study of clinical pictures and monoamine metabolism of Gilles de la Tourette syndrome].
Takano K; Ishiguro T
Seishin Shinkeigaku Zasshi; 1993; 95(1):1-29. PubMed ID: 7685527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
